Table 3.
In vivo toxicity of moniliformin and Alternaria mycotoxins.
Animal Species | Mycotoxin | Route of Exposure | Exposure Time | Exposure Dose | Effect | Reference |
---|---|---|---|---|---|---|
mouse | MON | po-ip | 1x | LD50: 20.9 (♀) 29.1 (♂) mg/kg bw (ip), survivors clinically healthy | [13,92] | |
TeA | iv-po | 1x | 0–398 mg/kg bw | LD50: 76–162 (iv) and 81–209 (po), vomiting, diarrhea, hemorrhages, death | ||
Sprague-Dawley rats | MON | po | 1x | 5 mg/kg bw | no clinical signs | [13,98,99] |
1x | 10 mg/kg bw | ↓ activity for 24 h, respiratory changes, trembling, piloerection, complete recovery within 48 h | ||||
1x | 25–50 mg/kg bw | respiratory and cardiovascular changes, collapse, convulsion and death within 48–83 min | ||||
28 days | 3–6 mg/kg bw | no clinical symptoms, no effect on leucocyte and red blood cell counts, food and water consumption or organ and body weights, ↓ phagocytic activity of neutrophils | ||||
TeA | iv-po | 1x | 0–398 mg/kg bw | LD50: 83–157 (iv) and LD50: 168–240 (po), vomiting, diarrhea, hemorrhages, death | ||
Syrian golden hamster | AME | ip | 1x | 200 mg/kg bw | severe necrosis and coalescence of visceral organs lethargy, breathing difficulties, flaccid hind limbs↑ resorptions and ↓ fetal weight |
[100] |
chicken embryo | MON | injection | 1x | LD50: 2.8 µg/egg, no gross teratogenic effects in survivors | [92] | |
TeA | injection | 1x | 150–1500 µg/egg | dose-related mortality, LD50: 548 µg/egg | [101] | |
1-day old chicken | MON | po | 1x | 0–16 mg/kg bw | LD50: 5.4 mg/kg bw (crop intubation), survivors clinically healthy | [92] |
broiler chickens | MON | feed | 21 days | 200 mg/kg feed | death (56%) ↑ kidney, heart and liver weight ↑ serum albumin, total protein and aspartate aminotransferase |
[11,14,102] |
100 mg/kg feed | ↓ feed intake and body weight gain ↑ hearth weight ↑ kidney weight if feed also contained 200 mg FB1/kg ↑ incidence of large pleomorphic cardiomyocyte nuclei loss of cardiomyocyte cross striations mild focal renal tubular mineralization |
|||||
feed | 42 days (day 7–49) | 50 mg/kg feed | mortality (13.3%) ↑ feed consumption, ↓ body weight gain, ↓ feed conversion ↑ relative heart and proventriculus weight, ↓ mean corpuscular volume ↑ serum gamma glutamyltransferase activity loss of cardiomyocyte cross striations ↑ cardiomyocyte nuclear size |
|||
25 mg/kg feed | mortality (7.8%) ↑ serum gamma glutamyltransferase activity |
|||||
TeA | po | 21 days | 1.25–2.5 mg/kg bw | ↓ weight gain and feed efficiency hemorrhages, erosions of the gizzard, pale mottled spleens, edema of the myocardium, microscopic congestions of blood vessels and hemorrhages |
||
White leghorn chicken | TeA | po | 1x | LD50: 37.5 mg/kg bw with hemorrhages of the musculature of the thigh, breast, heart and subcutaneous tissues | [14] | |
21 days | 0.63 mg/kg bw | pathological changes in spleen and gizzard but no extensive hemorrhages microscopic congestions of blood vessels and hemorrhages |
||||
21 days | 1.25–2.5 mg/kg bw | ↓ weight gain and feed efficiency hemorrhages, erosions of the gizzard, pale mottled spleens, edema of the myocardium, microscopic congestions of blood vessels and hemorrhages |
||||
turkeys | MON | feed | 91 days (day 7–98) | 25, 37.5, 50 mg/kg feed | ↑ relative heart weight | [102] |
37.5, 50 mg/kg feed | ↑ relative liver weight | |||||
50 mg/kg feed | loss of cardiomyocyte cross striations ↑ cardiomyocyte nuclear size, ↑ number of cardiomyocyte mitotic figures |
|||||
turkey poults | MON | feed | 21–28 days | 100 mg/kg feed | ↓ feed intake, body weight gain, feed efficiency, ↓ relative thymus, bursa and spleen weights, ↓ primary and secondary antibody response to inactivated Newcastle disease virus, ↓ systemic clearance of E. coli |
[103] |
Japanese quail | MON | feed | 35 days | 100 mg/kg feed | cardiomegaly, myocardial congestion, hypertrophy, myocardial disarray, ↑ mitochondria, resulting in separation of muscle fibers, swollen and deformed mitochondria with degenerative changes. Congestion, hemorrhages and degenerative changes more pronounced and extensive disruption of muscle fibers and destruction of Z-bands when feed contained both MON and fumonisin B1. Death. | [12] |
barrow | MON | feed | 28 days | 100 mg/kg feed | acute mortality due to apparent cardiac failure ↓ body weight gain ↓ body weight gain, feed consumption and feed efficiency when feed also contained FB1 |
[104] |
dog | TeA | iv-po | 1x | 25–50 mg/kg bw | severe tachycardia, massive diffuse hemorrhages, (bloody) diarrhea | [13] |
iv | 3x | 20 mg/kg bw | severe hemorrhagic gastro-enteropathy, death | |||
iv-po | 6–30 days | 0.0625–11.2 mg/kg bw | salivation, emesis, tachycardia, hemorrhagic gastro-enteropathy, death | |||
monkey | TeA | iv | 3x | 20 mg/kg bw | severe hemorrhagic gastro-enteropathy, death | [13] |
iv-po | 7–45 days | 11.2–89.6 mg/kg | salivation, emesis, hemorrhagic gastro-enteropathy, death |
↓ decrease; ↑ increase.